Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
Nicolas Burdin(La Jolla Institute for Immunology), Mitchell Kronenberg(La Jolla Institute for Immunology), Ming Gui(Fox Chase Cancer Center), Laurent Brossay, Kyoko Hayakawa(Fox Chase Cancer Center), Masaru Taniguchi(Nagoya City University), Stephen T. Smiley(National Institutes of Health), Yasuhiko Koezuka, Michael J. Grusby(Harvard University)
PubMed
October 1, 1998
Cited by 382
Related Papers
Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.
|The Journal of Experimental Medicine|1991|1.6k
B Cell Development Pathways
|Annual Review of Immunology|2001|1.2k
Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4
|The Journal of Immunology|2001|953
Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
|The Journal of Experimental Medicine|2000|879
The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.
|The Journal of Experimental Medicine|1983|804